U.S. market Closed. Opens in 2 hours 1 minute

DIAX | Nuveen Dow 30 Dynamic Overwrite Fund Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for DIAX we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is moderate, Growth is bad and Health is weak.

Valuation (47%)

Company Industry
P/E Ratio (TTM) 8.70 37.97
PEG Ratio (TTM) 1.40 5.36
P/S Ratio (TTM) 28.19 68.76
P/B Ratio (TTM) 0.93 71.92
P/FCF Ratio (TTM) N/A 84.76
Price to 5YR AVG Earnings Ratio N/A 12.93
Price to 5YR AVG FCF Ratio N/A 47.54

Profitability (55%)

Company Industry
ROA (TTM) 10.43% 638.84%
ROE (TTM) 10.55% 9.98%
Net Profit Margin (TTM) 324.21% -13.10%
ROIC 5YR AVG N/A 15.68%

Growth (50%)

4QTR AVG 3YR AVG 5YR AVG
EPS 46.47% 309.54% N/A
Revenue 20.90% 324.75% N/A
Net Income 44.93% 314.82% N/A
Cash Flow N/A N/A N/A

Health (42%)

Company Industry
Current Ratio (TTM) 0.01 4.98
Quick Ratio (TTM) 0.01 4.39
D/E Ratio (TTM) 0.00 0.82
Interest Coverage (TTM) N/A 8.78
Piotroski F-Score 5 6
Altman Z-Score 25.11 6.34
LTL to 5YR AVG FCF N/A 7.49
Shares Outstanding Growth 5YR AVG N/A 3.41%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙